Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 3/2012

01.03.2012 | Retinal Disorders

Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography

verfasst von: Susann Mißner, Ulrich Kellner

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To compare various screening methods for the early diagnosis of retinal dysfunction in patients with long-term chloroquine (CQ) and hydroxychloroquine (HCQ) treatment.

Methods

Twenty patients with long-term CQ/HCQ treatment underwent ophthalmologic evaluation including visual acuity testing, ophthalmoscopy, fluorescein angiography, color vision tests, visual field and multifocal electroretinography (mfERG).

Results

In 14 patients, retinal dysfunction was indicated in the mfERG (reduced amplitudes and/or delayed implicit times) in the parafoveal area. Towards the periphery, the function was normal or only moderately reduced. Ophthalmoscopy and fluorescein angiography identified pathologic retinal changes in seven of these 14 patients. Six patients had normal mfERG, ophthalmoscopy, and fluorescein angiography. Results of color vision and visual field testing were variable even in patients with morphologic alterations.

Conclusion

The use of mfERG may detect retinal dysfunction in a considerable number of eyes with normal ophthalmocopy and fluorescein angiography. The higher variability of color vision and visual field testing results suggests the use of mfERG as primary screening tool for retinal dysfunction in long-term CQ/HCQ treatment.
Literatur
1.
Zurück zum Zitat Hobbs HE, Sorby A, Freedman A (1959) Retinopathy following chloroquine therapy. Lancet 2:478–480PubMedCrossRef Hobbs HE, Sorby A, Freedman A (1959) Retinopathy following chloroquine therapy. Lancet 2:478–480PubMedCrossRef
2.
Zurück zum Zitat Shearer RV, Dubois EL (1967) Ocular changes induced by long-term hydroxychloroquine (plaquenil) therapy. Am J Ophthalmol 64:245–252PubMed Shearer RV, Dubois EL (1967) Ocular changes induced by long-term hydroxychloroquine (plaquenil) therapy. Am J Ophthalmol 64:245–252PubMed
3.
Zurück zum Zitat Bishara SA, Matamoros N (1989) Evaluation of several tests in screening for chloroquine maculopathy. Eye 3:777–782PubMedCrossRef Bishara SA, Matamoros N (1989) Evaluation of several tests in screening for chloroquine maculopathy. Eye 3:777–782PubMedCrossRef
4.
Zurück zum Zitat American College of Rheumatology Ad Hoc Committee on Clinical Guidelines (1996) Guidelines for monitoring drug therapy in rheumatoid arthritis. Arthritis Rheum 39:723–727CrossRef American College of Rheumatology Ad Hoc Committee on Clinical Guidelines (1996) Guidelines for monitoring drug therapy in rheumatoid arthritis. Arthritis Rheum 39:723–727CrossRef
5.
Zurück zum Zitat Easterbrook M (1999) Detection and prevention of maculopathy associated with antimalarial agents. Int Ophthalmol Clin 39:49–57PubMedCrossRef Easterbrook M (1999) Detection and prevention of maculopathy associated with antimalarial agents. Int Ophthalmol Clin 39:49–57PubMedCrossRef
6.
Zurück zum Zitat Alacron GS (2002) How frequently and how soon should we screen our patients for the presence of antimalarial retinopathy? Arthritis Rheum 46:561 Alacron GS (2002) How frequently and how soon should we screen our patients for the presence of antimalarial retinopathy? Arthritis Rheum 46:561
7.
Zurück zum Zitat Semmer AE, Lee MS, Harrison AR, Olsen TW (2008) Hydroxychloroquine retinopathy screening. Br J Ophthalmol 92:1653–1655PubMedCrossRef Semmer AE, Lee MS, Harrison AR, Olsen TW (2008) Hydroxychloroquine retinopathy screening. Br J Ophthalmol 92:1653–1655PubMedCrossRef
8.
Zurück zum Zitat Mamor MF, Carr RE, Easterbrook M, Farjo AA, Mieler WF (2002) Recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Opthalmology 109:1377–1382CrossRef Mamor MF, Carr RE, Easterbrook M, Farjo AA, Mieler WF (2002) Recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Opthalmology 109:1377–1382CrossRef
9.
Zurück zum Zitat Browning DJ (2002) Hydroxychloroquine and chloroquine retinopathy: screening for drug toxicity. Am J Ophthalmol 133:649–656PubMedCrossRef Browning DJ (2002) Hydroxychloroquine and chloroquine retinopathy: screening for drug toxicity. Am J Ophthalmol 133:649–656PubMedCrossRef
10.
Zurück zum Zitat Warner AE (2001) Early hydroxychloroquine macular toxicity. Arthritis Rheum 4:1959–1961CrossRef Warner AE (2001) Early hydroxychloroquine macular toxicity. Arthritis Rheum 4:1959–1961CrossRef
11.
Zurück zum Zitat Kellner U, Kraus H, Foerster MH (2000) Multifocal ERG in chloroquine retinopathy: regional variance of retinal dysfunction. Graefes Arch Clin Exp Ophthalmol 238:94–97PubMedCrossRef Kellner U, Kraus H, Foerster MH (2000) Multifocal ERG in chloroquine retinopathy: regional variance of retinal dysfunction. Graefes Arch Clin Exp Ophthalmol 238:94–97PubMedCrossRef
12.
Zurück zum Zitat So SC, Hedges TR, Schuman JS, Quireza ML (2003) Evaluation of hydroxychloroquine retinopathy with multifocal electroretinography. Ophthalmic Surg Lasers Imaging 34:251–258PubMed So SC, Hedges TR, Schuman JS, Quireza ML (2003) Evaluation of hydroxychloroquine retinopathy with multifocal electroretinography. Ophthalmic Surg Lasers Imaging 34:251–258PubMed
13.
Zurück zum Zitat Penrose PJ, Tzekov RT, Sutter EE, Fu AD, Allen AW Jr, Fung WE, Oxford KW (2003) Multifocal electroretinography evaluation for early detection of retinal dysfunction in patients taking hydroxychloroquine. Retina 23:503–512PubMedCrossRef Penrose PJ, Tzekov RT, Sutter EE, Fu AD, Allen AW Jr, Fung WE, Oxford KW (2003) Multifocal electroretinography evaluation for early detection of retinal dysfunction in patients taking hydroxychloroquine. Retina 23:503–512PubMedCrossRef
14.
Zurück zum Zitat Maturi RK, Yu M, Weleber RG (2004) Multifocal electroretinographic evaluation of long-term hydroxychloroquine users. Arch Ophthalmol 122:973–981PubMedCrossRef Maturi RK, Yu M, Weleber RG (2004) Multifocal electroretinographic evaluation of long-term hydroxychloroquine users. Arch Ophthalmol 122:973–981PubMedCrossRef
15.
Zurück zum Zitat Moschos MN, Moschos MM, Apostolopoulos M, Mallias JA, Bouros C, Theodossiadis GP (2004) Assessing hydroxychloroquine toxicity by the multifocal ERG. Doc Ophthalmol 108:47–53PubMedCrossRef Moschos MN, Moschos MM, Apostolopoulos M, Mallias JA, Bouros C, Theodossiadis GP (2004) Assessing hydroxychloroquine toxicity by the multifocal ERG. Doc Ophthalmol 108:47–53PubMedCrossRef
16.
Zurück zum Zitat Tzekov RT, Serrato A, Marmor MF (2004) ERG findings in patients using hydroxychloroquine. Doc Ophthalmol 108:87–97PubMedCrossRef Tzekov RT, Serrato A, Marmor MF (2004) ERG findings in patients using hydroxychloroquine. Doc Ophthalmol 108:87–97PubMedCrossRef
17.
Zurück zum Zitat Lai TY, Chan WM, Li H, Lai RY, Lam DS (2005) Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy. Am J Ophthalmol 140:794–807PubMedCrossRef Lai TY, Chan WM, Li H, Lai RY, Lam DS (2005) Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy. Am J Ophthalmol 140:794–807PubMedCrossRef
18.
Zurück zum Zitat Lai TY, Ngai JW, Chan WM, Lam DS (2006) Visual field and multifocal electroretinography and their correlations in patients on hydroxychloroquine therapy. Doc Ophtalmol 112:177–187CrossRef Lai TY, Ngai JW, Chan WM, Lam DS (2006) Visual field and multifocal electroretinography and their correlations in patients on hydroxychloroquine therapy. Doc Ophtalmol 112:177–187CrossRef
19.
Zurück zum Zitat Kellner U, Renner AB, Tillack H (2006) Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine. Invest Ophthalmol Vis Sci 47:3531–3538PubMedCrossRef Kellner U, Renner AB, Tillack H (2006) Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine. Invest Ophthalmol Vis Sci 47:3531–3538PubMedCrossRef
20.
Zurück zum Zitat Lyons JS, Severns ML (2009) Using multifocal ERG ring ratios to detect and follow Plaquenil retinal toxicity: a review: Review of mfERG ring ratios in Plaquenil toxicity. Doc Ophthalmol 118:29–36PubMedCrossRef Lyons JS, Severns ML (2009) Using multifocal ERG ring ratios to detect and follow Plaquenil retinal toxicity: a review: Review of mfERG ring ratios in Plaquenil toxicity. Doc Ophthalmol 118:29–36PubMedCrossRef
21.
Zurück zum Zitat Marmor MF, Kellner U, Lai TY, Lyons JS, Mieler WF (2011) Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology 118:415–422PubMedCrossRef Marmor MF, Kellner U, Lai TY, Lyons JS, Mieler WF (2011) Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology 118:415–422PubMedCrossRef
22.
Zurück zum Zitat Kellner U, Kleine-Hartlage P, Foerster MH (1992) Cone dystrophies: clinical and electrophysiological findings. German J Ophthalmol 1:105–109 Kellner U, Kleine-Hartlage P, Foerster MH (1992) Cone dystrophies: clinical and electrophysiological findings. German J Ophthalmol 1:105–109
23.
Zurück zum Zitat Marmor MF, Hood DC, Keating D, Kondo M, Seeliger MW, Miyake Y (2003) Guidelines for basic multifocal electroretinography (mfERG) (for the International Society for Clinical Electrophysiology of Vision). Doc Ophthalmol 106:105–115PubMedCrossRef Marmor MF, Hood DC, Keating D, Kondo M, Seeliger MW, Miyake Y (2003) Guidelines for basic multifocal electroretinography (mfERG) (for the International Society for Clinical Electrophysiology of Vision). Doc Ophthalmol 106:105–115PubMedCrossRef
24.
Zurück zum Zitat Polyak SL (1941) The retina. University of Chicago Press, Chicago Polyak SL (1941) The retina. University of Chicago Press, Chicago
25.
Zurück zum Zitat Hood DC, Seiple W, Holopigian K, Greenstein V, Carr RE (1997) A comparison of components of multi-focal and full-field ERGs. Vis Neurosci 14:533–544PubMedCrossRef Hood DC, Seiple W, Holopigian K, Greenstein V, Carr RE (1997) A comparison of components of multi-focal and full-field ERGs. Vis Neurosci 14:533–544PubMedCrossRef
26.
Zurück zum Zitat Bernstein HN, Ginsberg J (1964) The pathology of chloroquine retinopathy. Arch Ophthalmol 71:238–245PubMedCrossRef Bernstein HN, Ginsberg J (1964) The pathology of chloroquine retinopathy. Arch Ophthalmol 71:238–245PubMedCrossRef
27.
Zurück zum Zitat Rosenthal AR, Kolb H, Bergsma D, Huxsoll D, Hopkins JL (1978) Chloroquine retinopathy in the rhesus monkey. Invest Ophthalmol Vis Sci 17:1158–1175PubMed Rosenthal AR, Kolb H, Bergsma D, Huxsoll D, Hopkins JL (1978) Chloroquine retinopathy in the rhesus monkey. Invest Ophthalmol Vis Sci 17:1158–1175PubMed
28.
Zurück zum Zitat Wetterholm DH, Winter FC (1964) Histopathology of chloroquine retinal toxicity. Arch Ophthalmol 71:82–87PubMedCrossRef Wetterholm DH, Winter FC (1964) Histopathology of chloroquine retinal toxicity. Arch Ophthalmol 71:82–87PubMedCrossRef
29.
Zurück zum Zitat Shroyer NF, Lewis RA, Lupski JR (2001) Analysis of the ABCR (ABCA4) gene in 4-aminoquinoline retinopathy: is retinal toxicity by chloroquine and hydroxychloroquine related to Stargardt disease? Am J Ophthalmol 131:761–766PubMedCrossRef Shroyer NF, Lewis RA, Lupski JR (2001) Analysis of the ABCR (ABCA4) gene in 4-aminoquinoline retinopathy: is retinal toxicity by chloroquine and hydroxychloroquine related to Stargardt disease? Am J Ophthalmol 131:761–766PubMedCrossRef
30.
Zurück zum Zitat Mahon GJ, Anderson HR, Gardiner TA, McFarlane S, Archer DB, Stitt AW (2004) Chloroquine causes lysosomal dysfunction in neural retina and RPE: implications for retinopathy. Curr Eye Res 28:277–284PubMedCrossRef Mahon GJ, Anderson HR, Gardiner TA, McFarlane S, Archer DB, Stitt AW (2004) Chloroquine causes lysosomal dysfunction in neural retina and RPE: implications for retinopathy. Curr Eye Res 28:277–284PubMedCrossRef
31.
Zurück zum Zitat Bienfang D, Coblyn JS, Liang MH, Corzillius M (2000) Hydroxychloroquine retinopathy despite regular ophthalmologic evaluation: a consecutive series. J Rheumatol 27:2703–2706PubMed Bienfang D, Coblyn JS, Liang MH, Corzillius M (2000) Hydroxychloroquine retinopathy despite regular ophthalmologic evaluation: a consecutive series. J Rheumatol 27:2703–2706PubMed
32.
Zurück zum Zitat Rüther K, Foerster J, Berndt S, Schroeter J (2007) Variabilitat der retinotoxischen Gesamtdosis Chloroquin/Hydroxychloroquin. Ophthalmologe 104:875–887PubMedCrossRef Rüther K, Foerster J, Berndt S, Schroeter J (2007) Variabilitat der retinotoxischen Gesamtdosis Chloroquin/Hydroxychloroquin. Ophthalmologe 104:875–887PubMedCrossRef
33.
Zurück zum Zitat Rodriguez-Padilla JA, Hedges TR 3rd, Monson B, Srinivasan V, Wojtkowski M, Reichel E, Duker JS, Schuman JS, Fujimoto JG (2007) High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy. Arch Ophthalmol 125:775–780PubMedCrossRef Rodriguez-Padilla JA, Hedges TR 3rd, Monson B, Srinivasan V, Wojtkowski M, Reichel E, Duker JS, Schuman JS, Fujimoto JG (2007) High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy. Arch Ophthalmol 125:775–780PubMedCrossRef
34.
Zurück zum Zitat Kellner S, Weinitz S, Kellner U (2009) Spectral domain optical coherence tomography detects early stages of chloroquine retinopathy similar to multifocal electroretinography, fundus autofluorescence and near-infrared autofluorescence. Br J Ophthalmol 93:1444–1447PubMedCrossRef Kellner S, Weinitz S, Kellner U (2009) Spectral domain optical coherence tomography detects early stages of chloroquine retinopathy similar to multifocal electroretinography, fundus autofluorescence and near-infrared autofluorescence. Br J Ophthalmol 93:1444–1447PubMedCrossRef
Metadaten
Titel
Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography
verfasst von
Susann Mißner
Ulrich Kellner
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 3/2012
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-011-1753-2

Weitere Artikel der Ausgabe 3/2012

Graefe's Archive for Clinical and Experimental Ophthalmology 3/2012 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.